Matribhumi Samachar English
Vancouver, British Columbia–(Newsfile Corp. – November 7, 2025) – C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) (“C21” or the “Company“), a vertically integrated cannabis company, today announced it will release its financial results for the second quarter ended September 30, 2025, on Tuesday, November 11, 2025, before market open. For …
Read More »Sherpa Completes Purchase of Remaining Ownership of the Bakar Property on Northern Vancouver Island, British Columbia
Vancouver, British Columbia–(Newsfile Corp. – November 7, 2025) – Sherpa II Holdings Corp. (TSXV: SHRP) (the “Company” or “Sherpa II“) is pleased to announce that, further to the definitive purchase agreement (the “Agreement”) dated June 3, 2025 and initially announced on June 4, 2025, it has completed the purchase of the remaining …
Read More »Colibri Announces Closing of Second Tranche of Its Over-subscribed Non-Brokered Offering
Dieppe, New Brunswick–(Newsfile Corp. – November 7, 2025) – Colibri Resource Corporation (TSXV: CBI) (“Colibri” or the “Company”) is pleased to announce that, further to its news release of November 3, 2025, it has closed a second tranche (“Tranche 2”) of its non-brokered private placement (the “Offering”) for gross proceeds of …
Read More »First Phosphate Announces Non-Brokered Private Placement to Accommodate Existing Investor
THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES Saguenay, Quebec–(Newsfile Corp. – November 7, 2025) – First Phosphate Corp. (CSE: PHOS) (OTCQX: FRSPF) (FSE: KD0) (“First Phosphate” or the “Company”) is pleased to announce a non-brokered private placement to a strategic investor for gross proceeds of a minimum of …
Read More »CEO.CA’s Inside the Boardroom: EnviroGold Unlocks $3.4 Trillion in Mine Waste with Patented Recovery Process
Toronto, Ontario–(Newsfile Corp. – November 7, 2025) – CEO.CA (“CEO.CA”), the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior mining explorers. Founded in 2012, CEO.CA, a wholly owned subsidiary of EarthLabs, Inc., is one of the most popular free financial websites and …
Read More »RainCastle Achieves 62% Growth Just 2 Years After Founder-Led Acquisition
RainCastle’s post-acquisition growth of 62% reflects a successful fusion of creative legacy and digital innovation, strengthening its position as a leading agency for life sciences and healthcare brands. Boston, Massachusetts–(Newsfile Corp. – November 7, 2025) – Award-winning full-service design agency RainCastle recently announced a 62% increase in business growth over …
Read More »Highland Critical Minerals Corp. Enters into Binding Letter of Intent to Acquire Mining Claims Located in the Territory of Nunavut
Toronto, Ontario–(Newsfile Corp. – November 7, 2025) – Highland Critical Minerals Corp. (CSE: HLND) (“Highland” or the “Company“) is pleased to announce that it has entered into a binding letter of intent (the “LOI“) to acquire a 100% interest in certain mining claims located in the Territory of Nunavut, Canada. …
Read More »BioHarvest Sciences Announces Pricing of $17.4 Million Upsized Public Offering of Common Stock
Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – November 7, 2025) – BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) (“BioHarvest” or “the Company”), a company pioneering its patented Botanical Synthesis technology platform, announces the pricing of an underwritten public offering of 2,485,000 shares of common stock, no par value, and …
Read More »Altamira Gold Receives $6.3 Million Through Exercise of Warrants
Vancouver, British Columbia–(Newsfile Corp. – November 7, 2025) – Altamira Gold Corp. (TSXV: ALTA) (FSE: T6UP) (OTCQB: EQTRF) (“Altamira” or the “Company“), is pleased to announce that the Company has raised $6,284,820 since September 1, 2025 as a result of the exercise of 31,292,400 share purchase warrants and 131,700 broker’s warrants …
Read More »Phio Pharmaceuticals Announces INTASYL PH-762 is Named Immunomodulatory Solution of the Year in the BioTech Breakthrough Award Program
King of Prussia, Pennsylvania–(Newsfile Corp. – November 7, 2025) – Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics using its proprietary INTASYL® siRNA gene silencing technology to eliminate cancer. Phio announced today that its INTASYL compound PH-762 is the winner of the 2025 Immunomodulatory Solution of …
Read More »